vs
Side-by-side financial comparison of PERRIGO Co plc (PRGO) and SEALED AIR CORP (SEE). Click either name above to swap in a different company.
SEALED AIR CORP is the larger business by last-quarter revenue ($1.4B vs $1.1B, roughly 1.3× PERRIGO Co plc). SEALED AIR CORP runs the higher net margin — 3.1% vs -127.8%, a 130.9% gap on every dollar of revenue. On growth, SEALED AIR CORP posted the faster year-over-year revenue change (2.6% vs -2.5%). SEALED AIR CORP produced more free cash flow last quarter ($257.7M vs $148.6M). Over the past eight quarters, SEALED AIR CORP's revenue compounded faster (2.7% CAGR vs 1.3%).
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
Sealed Air Corporation is a global provider of innovative packaging and protective solutions. Its core offerings include cushioning materials, food safety and preservation packaging, and sustainable waste-reducing packaging systems, serving retail, e-commerce, food and beverage, and industrial manufacturing markets worldwide.
PRGO vs SEE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.4B |
| Net Profit | $-1.4B | $43.8M |
| Gross Margin | 32.6% | 28.6% |
| Operating Margin | -116.0% | 11.4% |
| Net Margin | -127.8% | 3.1% |
| Revenue YoY | -2.5% | 2.6% |
| Net Profit YoY | -3093.9% | 700.0% |
| EPS (diluted) | $-10.23 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.0B | $1.3B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.0B | $1.3B | ||
| Q4 24 | $1.1B | $1.4B | ||
| Q3 24 | $1.1B | $1.3B | ||
| Q2 24 | $1.1B | $1.3B | ||
| Q1 24 | $1.1B | $1.3B |
| Q4 25 | $-1.4B | $43.8M | ||
| Q3 25 | $7.5M | $255.1M | ||
| Q2 25 | $-8.4M | $93.1M | ||
| Q1 25 | $-6.4M | $113.5M | ||
| Q4 24 | $-44.4M | $-7.3M | ||
| Q3 24 | $-21.0M | $91.7M | ||
| Q2 24 | $-108.4M | $98.3M | ||
| Q1 24 | $2.0M | $82.0M |
| Q4 25 | 32.6% | 28.6% | ||
| Q3 25 | 36.1% | 29.8% | ||
| Q2 25 | 34.4% | 30.7% | ||
| Q1 25 | 37.6% | 30.9% | ||
| Q4 24 | 33.9% | 30.0% | ||
| Q3 24 | 37.2% | 30.1% | ||
| Q2 24 | 37.0% | 31.2% | ||
| Q1 24 | 33.1% | 30.3% |
| Q4 25 | -116.0% | 11.4% | ||
| Q3 25 | 7.0% | 13.8% | ||
| Q2 25 | 4.3% | 15.0% | ||
| Q1 25 | 4.5% | 14.5% | ||
| Q4 24 | 10.0% | 11.7% | ||
| Q3 24 | 7.4% | 13.9% | ||
| Q2 24 | -2.5% | 15.4% | ||
| Q1 24 | -5.1% | 14.0% |
| Q4 25 | -127.8% | 3.1% | ||
| Q3 25 | 0.7% | 19.0% | ||
| Q2 25 | -0.8% | 7.0% | ||
| Q1 25 | -0.6% | 9.0% | ||
| Q4 24 | -3.9% | -0.5% | ||
| Q3 24 | -1.9% | 6.9% | ||
| Q2 24 | -10.2% | 7.4% | ||
| Q1 24 | 0.2% | 6.2% |
| Q4 25 | $-10.23 | $0.30 | ||
| Q3 25 | $0.05 | $1.73 | ||
| Q2 25 | $-0.06 | $0.63 | ||
| Q1 25 | $-0.05 | $0.77 | ||
| Q4 24 | $-0.32 | $-0.05 | ||
| Q3 24 | $-0.15 | $0.63 | ||
| Q2 24 | $-0.79 | $0.67 | ||
| Q1 24 | $0.01 | $0.56 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $344.0M |
| Total DebtLower is stronger | — | $3.3B |
| Stockholders' EquityBook value | $2.9B | $1.2B |
| Total Assets | $8.5B | $7.0B |
| Debt / EquityLower = less leverage | — | 2.65× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $344.0M | ||
| Q3 25 | $432.1M | $282.5M | ||
| Q2 25 | $454.2M | $354.4M | ||
| Q1 25 | $409.9M | $335.2M | ||
| Q4 24 | $558.8M | $371.8M | ||
| Q3 24 | $1.5B | $386.0M | ||
| Q2 24 | $542.8M | $388.6M | ||
| Q1 24 | $658.5M | $352.8M |
| Q4 25 | — | $3.3B | ||
| Q3 25 | — | $4.0B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.2B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | — | $4.3B | ||
| Q2 24 | — | $4.4B | ||
| Q1 24 | — | $4.5B |
| Q4 25 | $2.9B | $1.2B | ||
| Q3 25 | $4.4B | $1.2B | ||
| Q2 25 | $4.5B | $953.1M | ||
| Q1 25 | $4.4B | $797.9M | ||
| Q4 24 | $4.3B | $624.5M | ||
| Q3 24 | $4.6B | $771.2M | ||
| Q2 24 | $4.5B | $650.1M | ||
| Q1 24 | $4.7B | $598.3M |
| Q4 25 | $8.5B | $7.0B | ||
| Q3 25 | $10.1B | $7.1B | ||
| Q2 25 | $10.1B | $7.2B | ||
| Q1 25 | $9.8B | $7.0B | ||
| Q4 24 | $9.6B | $7.0B | ||
| Q3 24 | $11.2B | $7.3B | ||
| Q2 24 | $10.4B | $7.3B | ||
| Q1 24 | $10.6B | $7.2B |
| Q4 25 | — | 2.65× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | — | 4.18× | ||
| Q1 25 | — | 5.26× | ||
| Q4 24 | — | 6.72× | ||
| Q3 24 | — | 5.62× | ||
| Q2 24 | — | 6.81× | ||
| Q1 24 | — | 7.49× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.4M | $293.6M |
| Free Cash FlowOCF − Capex | $148.6M | $257.7M |
| FCF MarginFCF / Revenue | 13.4% | 18.5% |
| Capex IntensityCapex / Revenue | 2.4% | 2.6% |
| Cash ConversionOCF / Net Profit | — | 6.70× |
| TTM Free Cash FlowTrailing 4 quarters | $145.1M | $458.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.4M | $293.6M | ||
| Q3 25 | $51.7M | $165.9M | ||
| Q2 25 | $75.9M | $136.6M | ||
| Q1 25 | $-64.5M | $31.9M | ||
| Q4 24 | $312.6M | $244.2M | ||
| Q3 24 | $42.2M | $170.5M | ||
| Q2 24 | $9.5M | $188.2M | ||
| Q1 24 | $-1.4M | $125.1M |
| Q4 25 | $148.6M | $257.7M | ||
| Q3 25 | $29.8M | $119.6M | ||
| Q2 25 | $56.7M | $93.2M | ||
| Q1 25 | $-90.0M | $-12.0M | ||
| Q4 24 | $274.9M | $185.1M | ||
| Q3 24 | $15.1M | $115.2M | ||
| Q2 24 | $-18.9M | $129.5M | ||
| Q1 24 | $-26.5M | $78.0M |
| Q4 25 | 13.4% | 18.5% | ||
| Q3 25 | 2.9% | 8.9% | ||
| Q2 25 | 5.4% | 7.0% | ||
| Q1 25 | -8.6% | -0.9% | ||
| Q4 24 | 24.2% | 13.6% | ||
| Q3 24 | 1.4% | 8.6% | ||
| Q2 24 | -1.8% | 9.7% | ||
| Q1 24 | -2.4% | 5.9% |
| Q4 25 | 2.4% | 2.6% | ||
| Q3 25 | 2.1% | 3.4% | ||
| Q2 25 | 1.8% | 3.3% | ||
| Q1 25 | 2.4% | 3.5% | ||
| Q4 24 | 3.3% | 4.4% | ||
| Q3 24 | 2.5% | 4.1% | ||
| Q2 24 | 2.7% | 4.4% | ||
| Q1 24 | 2.3% | 3.6% |
| Q4 25 | — | 6.70× | ||
| Q3 25 | 6.89× | 0.65× | ||
| Q2 25 | — | 1.47× | ||
| Q1 25 | — | 0.28× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.86× | ||
| Q2 24 | — | 1.91× | ||
| Q1 24 | -0.70× | 1.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
SEE
| Protective Segment | $1.1B | 78% |
| Other | $292.0M | 21% |
| Pension Plans Defined Benefit | $7.9M | 1% |
